A clinical AI tool needs more than permission to enter the hospital. Someone must decide which regulator reviews it, what happens when its software changes and who pays for its use. A new US proposal attempts to connect those questions before they become separate institutional queues.
This article continues for subscribers. Subscribe to read the full analysis.
SectorFrame membership
Read the full story
Independent reporting for people putting AI to work. Sign in to check your access, or explore a subscription.